08803638 · Active · incorporated 12 years, 10 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series A
Exonate is a biotechnology company developing novel, non-invasive, small-molecule therapeutics for retinal vascular diseases, including diabetic eye disease.
Exonate Limited is a private limited company registered at Companies House under number 08803638, incorporated on 5 December 2013, with a registered office in Cambridge, Cambridgeshire. Its current status on the register is active. Its filed nature of business is manufacture of basic pharmaceutical products (SIC 21100). Sonde has indexed 86 filings for this company, including 6 funding rounds. Its most recent round closed in September 2026, raising £1.5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Sep 2026 | £1.5m | £150.00 |
| Round 5 | Mar 2019 | £1.7m | £81.00 |
| Round 4 | Nov 2016 | £978k | £61.00 |
| Round 3 | Jan 2016 | £471k | £61.00 |
| Round 2 | Apr 2015 | £792k | £56.00 |
| Round 1 | Apr 2014 | £393k | £50.00 |
Showing the 10 most recent of 86 filings.
See the complete cap table with every shareholder, founder tags, dilution across 30 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.